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Little is known concerning late outcome and prognostic
factors after acute myocardial infarction in the very elderly
(>75 years of age). Accordingly, this study compared the
clinical course and mortality rate for up to 1 year in a large
multicenter data base that included 702 patients >75 years
of age (mean ± SD 81 ± 4 years), with a less elderly subset
of 1,321 patients between 65 and 75 years of age (mean 70
± 3 years). The postdischarge 1year cardiac mortality rate
was 17.6% for those >75 years of age compared with
12.0% for patients between 65 and 75 years of age (p <
0.01). There were differences in the prevalence of several
factors, including female gender, history of angina pectoris,
history of congestive heart failure, smoking habits and
incidence of congestive heart failure during hospitalization.
Multivariate analyses of predictors of cardiac death in
hospital survivors selected different factors as important in
the two age subgroups; age was selected in the 65 to 75 year
Individuals >65 years of age account for 12% of the total
population in the United States, twice the proportion exist-
ing 20 years ago (I). This group is expected to increase by
20% in the next decade and is predicted to comprise> 20O/C of
the population by the year 2030 (I). The fastest growing
segment of the elderly is the group 285 years of age.
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age group but was not an independent predictor in the very
elderly. The survival curves beginning at day 10 for pa-
tients 65 to 75 and in those >75 years old were similar for
up to 90 days but diverged later. In the very elderly, 63%
of late cardiac deaths were sudden or due to new myocar-
dial infarction, similar to the causes of 67 % of deaths in the
younger age group.
The findings that death is delayed and appears to be
primarily due to an ischemic event or sudden death suggest
that in the convalescent phase after acute myocardial
infarction noninvasive studies currently applied in a signif-
icant number of patients 65 to 75 years of age could also be
used to identify high risk patients >75 years of age suitable
(in the absence of other major medical problems) for
coronary angiography and possible revascularization ther-
apy.
() Am Coli CardioI1990;16:784-92)
Cardiovascular disease is the most common disabling and
lethal medical problem among the elderly. Coronary heart
disease accounts for two thirds of all deaths in the age group
>65 years (2) and >50O/C of all patients hospitalized with
acute myocardial infarction are 265 years old (3). Although
this age group currently constitutes only 12% of the total
population. it utilizes 30% of the health care funds and
resources (4).
In previous studies of myocardial infarction in older
patients (5-10). the mortality rate was higher and signs of
congestive heart failure were more common among older
patients even though the older group has been differently
defined as age >65 years (7). >70 years (5.8.9) or 65 to 75
years (10) or analyzed by decade (6). Only two previous
studies (8.10) examined a broad spectrum of historical and
clinical data in younger compared with older patients. One of
these (8) was limited to patients with a first myocardial
infarction and in the other study (10) the older group was
0735-1097/90/S3.50
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only 65 to 75 years of age. Previous studies in our entire
population (11-14) and other populations (15) have shown
age to be an independent determinant of outcome. even
when clinical signs of heart failure were included in multi-
variate analyses. Many clinical trials of patients after myo-
cardial infarction (16-24) have had age restrictions for entry
so that current mortality trends for older patients with and
without newer therapies are not well established. Thus. little
is known about the factors that affect the clinical course and
survival after acute myocardial infarction in very elderly
patients (>75 years of age).
The purpose of the present study was to compare patients
>75 years of age with those between 65 and 75 years in a
large multicenter group without an upper age restriction (the
University of California. San Diego Collaborative Data-
base). Age >75 years was selected as a dividing point to
identify the very elderly subgroup because in the younger
cohort (65 to 75 years) age is rarely a factor in selecting
therapy.
Methods
Study patients. The study group consisted of 2.023 pa-
tients >65 years of age (including 702 patients>75 years old)
who were admitted to the hospital with acute myocardial
infarction. Patients in the current study comprised 46% of
the total data base. All patients were admitted within 24 h
after onset of symptoms to the University of California. San
Diego Medical Center. the Veterans Affairs Medical Center.
San Diego. the Naval Hospital of San Diego. Sharp Memo-
rial Hospital. San Diego. Vancouver General HospitaL Brit-
ish Columbia. Canada and Hopital CantonaL Geneva. Switz-
erland during the period from January I, 1979 to August I,
1989.
The diagnosis of acute myocardial infarction was estab-
lished by the presence of two of the followinR three criteria:
I) elevation of serum creatine kinase. 2) characteristic chest
pain. or 3) electrocardiographic (ECG) changes with evolu-
tion of Q waves. Non-Q wave infarction was diagnosed by
typical ST segment or T wave changes. or both. associated
with serum creatine kinase elevation. Data were obtained
prospectively with special data collection forms and were
maintained in a data base supported by the Specialized
Center of Research (SCOR) on Ischemic Heart Disease at
the University of California. San Diego Medical Center.
Data acquisition methods and definitions have been previ-
ously described in detail (II, 12). All patients were enrolled
after they signed written informed consent statements. The
purpose of the data base was to provide material for studies
concerning prognosis after acute myocardial infarction. Al-
though general hypotheses were specified beforehand. the
present study should be considered a retrospective subgroup
analysis.
Follow-up. Patients were contacted by telephone at 3. 6
and 12 months after admission. Follow-up data at I year
were obtained in >97% of patients eligible for I year
follow-up evaluation at the time of this analysis. Information
concerning deaths was obtained from hospital records or
death certificates. For some patients. telephone interviews
with the personal physician or family members were made to
clarify details. All available data were reviewed by a re-
search cardiologist or. in cases where there was doubt. by a
committee to establish cause of death by consensus deci-
sion. Cardiac deaths included those due to shock. congestive
heart failure. extension of myocardial infarction or new
myocardial infarction. as well as "other" cardiac deaths
such as those associated with catheterization procedures or
cardiac surgery and sudden deaths. Sudden cardiac death
was defined as that caused by a documented fatal arrhythmia
or unexpected death with no other apparent cause.
Only cardiac deaths were analyzed. In patients>75 years
of age. 15 deaths (14%) within I year were noncardiac
compared with 19 (13%) in patients between 65 and 75 years
of age.
Varia hies
Historical factors and findings from the physical exami-
nation. laboratory data. ECGs and chest X-ray films were
examined. Although age and gender were analyzed as part of
the historical data. race was not. The centers participating in
the study were known beforehand to have only small minor-
ity representation (later determined to be at most 3% black)
and race was not included as a study variable. Factors were
also examined from the discharge physical examination and
chest X-ray study and medications prescribed at discharge
were noted. The occurrence of angina pectoris after hospital
discharge was recorded at the follow-up evaluation. and the
first notation within 6 months was analyzed in the present
study.
Congestive heart failure. Patients were classified as hav-
ing congestive heart failure if two of the following findings
were present during the first 3 days: I) S3 gallop. 2) pulmo-
nary rales. or 3) grade 2:2 pulmonary venous congestion on
the chest X-ray film. These findings did not have to be
observed simultaneously. Pulmonary venous congestion on
X-ray film was graded as follows: 0 = no pulmonary conges-
tion. I = redistribution of blood flow. 2 = interstitial
pulmonary edema. 3 = localized intraalveolar edema. and
4 = diffuse alveolar edema (25).
Special studies. The rates of performance of various
diagnostic procedures (radionuclide ventriculography for
ejection fraction determination. 24 h ambulatory ECG mon-
itoring. exercise stress testing and coronary angiography)
and their results for patients discharged from the hospital
were examined. Such studies. generally performed using
standard procedures. were an optional part of the SCOR
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protocol. The decisions to perform the studies were made by
the patient's physician; it is possible that some bias exists
that may influence the reported results. Although standard
automated procedures were used for the tests, the exact
protocols and methods of data analysis were not standard-
ized.
Complex ventricular premature beats were coded accord-
ing to the criteria of Lown and Wolf (26), with the highest
grade observed being recorded. Patients were classified as
having no complex ventricular premature beats (Lown grade
oor I) if they had no or only occasional isolated unifocal
ventricular premature beats «30/h in all hours) and as
having complex ventricular premature beats (Lown grade
2:2) if they had frequent ventricular premature beats (> I
beat/min or 2:30 beats/h in any hour), multiform ventricular
premature beats, early ventricular premature beats (R on T
phenomenon) or ventricular tachycardia (more than 3 con-
secutive ventricular premature beats with a heart rate> 100
beats/min). Thus, patients in the group with complex ven-
tricular premature beats were classified on the basis of
ventricular premature beat frequency or multiformity.
An exercise test was considered positive if the patient
experienced ischemia (angina pectoris or 2: I mm of ST
segment depression). The test was considered negative if the
patient reached 2:6 metabolic exercise equivalents and a
heart rate 2: 100 beats/min if taking a beta-adrenergic block-
ing agent or 2:5 metabolic exercise equivalents (METs) and
70% of predicted maximal heart rate if not taking a beta-
blocker without experiencing ischemia. Otherwise, the test
was considered indeterminant. In addition, a few tests were
considered indeterminant if the patient was taking digitalis or
had bundle branch block.
The extent of coronary artery disease determined from
coronary angiography was classified according to the crite-
ria from the Coronary Artery Surgery Study (CASS) (27).
These criteria used 2:70% stenosis (50% for the left main
coronary artery) to define significant disease.
Comparison with another age group. Patients in our study
between ages 65 and 75 years of age were compared with
patients in this age group from the Multicenter Investigation
of the Limitation of Infarct Size (MillS) (10). When avail-
able, data from this report are included in the tables of this
study.
Statistics. Student's t test was used to compare group
means for continuous variables, and the chi-square test with
Yates' correction was used to compare the incidence of
discrete variables between groups. Standard deviations are
reported for continuous variables. Survival curves were
computed with standard actuarial methods (program PIL of
the Biomedical Statistical Software Package), and curves for
different subgroups were compared with the Mantel-Cox
statistic (28). Stepwise Cox regression analyses were per-
formed to evaluate the independent importance of prognos-
tic variables for cardiac death after hospital discharge to I
year (program P2L) (28). For some predictor variables, risk
ratios (mortality for subgroup with factor/mortality for sub-
group without factor) were computed and compared (29).
Results
Comparison of Patients Aged >75 Years With
Those Aged 65 to 75 Years
History and clinical course in all study patients (2:65 years
of age) (Table 1). The mean age of patients>75 years old
(n = 702. 16% of the total study group) was 81 ± 4 years
(range 76 to 95). For patients 65 to 75 years of age (n = 1,321,
30% of the total study group), the mean age was 70 ± 3
years. Patients>75 years old were more often women, more
often had a history of congestive heart failure and less often
were smokers than were those 65 to 75 years. Patients>75
years old exhibited evidence of heart failure more often (65%
versus 53%. p < 0.00 I) and atrial fibrillation (29% versus
19%. p < 0.001), but did not have a higher incidence of other
severe complications (Table I).
The combined rate of acute thrombolysis, percutaneous
transluminal coronary angioplasty and emergent coronary
artery bypass waft surgery was higher in patients 65 to 75
years of age (5%) than in those>75 years old (I %). All of
these acute interventions were performed in patients admit-
ted after mid 1984 and would represent a higher proportion
of patients admitted since then.
The MillS cohort patients 65 to 75 years of age (10) were
generally similar to our patients 65 to 75 years of age for the
historical and in-hospital variables recorded, except that
more patients in the MillS group were women (37% versus
29%, p < 0.02). Rates of previous hypertension or conges-
tive heart failure in the hospital were not compared statisti-
cally because of differences in definitions.
In-hospital cardiac death. In-hospital cardiac death for
patients >75 years of age was 19.9% compared with 12.2%
for patients between 65 and 75 years (p < 0.001) and patients
>75 years had a slightly longer hospital stay. The in-hospital
cardiac mortality rate of patients with a Q wave myocardial
infarction was more than twice that of patients with a non-Q
wave infarction in both age groups (p < 0.0 I). Patients with
indeterminate location of infarction are also included in the
data for total cardiac deaths. In the MIllS cohort (10),
patients 65 to 75 years had a 13.8% in-hospital mortality rate.
Even in the absence of congestive heart failure, patients>75
years old in our study experienced nearly twice the in-
hospital mortality rate of those aged 65 to 75 years (8.1%
versus 4.6%, respectively, p < 0.06). Both age groups had a
high in-hospital mortality rate if congestive heart failure was
present (26% and 19%. respectively, p = NS) compared with
that in the older and younger cohorts if heart failure was
absent (8% and 5%, respectively). The in-hospital mortality
Table 2. Comparison of Discharge Evaluation and Therapy in
\,710 Patients Discharged Alive From the Hospital
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Table 1. Comparison of Variables From the History and Clinical
Course for All 2,023 Patients >65 Years of Age Admitted to
the Study
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65-75 Years
*p < 0.00 I, tp < 0.0 I and +p < 0.05 for our patients aged 65-75 versus
>75 years; §p < 0.05 for our patients aged 65-75 years versus MillS (10).
AV = atrioventricular: BUN = blood urea nitrogen; CK = creatine kinase:
Cong = congestive; DBP = diastolic blood pressure: Max = maximal: MI =
myocardial infarction; MillS = Multicenter Investigation of the Limitation of
Infarct Size; 3' = third degree.
Current Study MillS
>75 Years 65-75 Years 65-75 Years
702 IJ21 217
81 :±: 4 70 :±: 3* 69 :±: 3
44 29* m
*p < 0.001, tp < 0.01 and +p < 0.05 for 65-75 versus >75 years of age.
CABG = coronary artery bypass grafting; ECG = electrocardiogram:
LVEF = left ventricular ejection fraction: MI = myocardial infarction: PTCA
= percutaneous trans luminal coronary angioplasty; Pulm cong = pulmonary
congestion: vent = ventriculography; VPCs = ventricular premature com-
plexes during 24 h ambulatory ECG monitoring.
No.
Age (yr)
Women (%)
History (%)
Angina pectoris
Previous MI
Cong heart failure
Hypertension
Diabetes
Smoking (%)
Never
Quit
Presently
Location of infarction (%)
Inferoposterior
Anterolateral
Non-Q wave
Indeterminate
Laboratory values
Max CK (IU/liter)
Max BUN (mg/dl)
Complications (%)
Cong heart failure
3' AV block
Atrial fibrillation
Persistent pain
Extension of MI
Hospital cardiac mortality (%)
Q wave
Non-Q wave
Total
Time in hospital (days)
50 44+
33 33
23 14*
47 48
17 20
50 32*
34 35
26 32
28 34
33 32
28 24
II 10
1,008 :±: 829 1.162 :±: 829t
31 :±: 15 25 :±: 15*
65 53*
6 5
29 19*
25 24
5 6
25. I 22.7*
10.2 6.5
19.9 12.2*
17 :±: 12 14 :+: 7
42
28
14
64
24
35
63
44
14
8
13.8
Patients discharged Ino.)
Discharge examination 1'7r I
SJ gallop
Basilar rales
Discharge X-ray study
Pulm cong grade 2: 2 (%)
Cardiothoracic ratio
Discharge medication 1'7r)
Antiarrhythmic agent
Beta-blocker
Digitalis
Diuretic drug
Special studies
Radionuclide vent (%)
LVEF
Ambulatory ECG I'!cl
Complex VPCs ('7r)
Exercise test ('7r)
Abnormal (% I
Coronary angiogram
3 vessel disease ('7r)
Interventions (c,'c)
CABG or PTCA within 60 days
CABG or PTCA within I year
Follow-up ('7r)
Angina within 6 months
Nonfatal MI
Index Q wave
Index non-Q wave
Total
Cardiac mortality postdischarge to I year
Index Q wave MI
Index non-Q wave MI
Total
559
6
8
8
0.52 :±: 0.06
24
27
44
50
63
0.46 :±: 0.15
58
52
17
30
8
32
36
6.4
7.4
6.2
15.7
17.8
17.6
I, 15 I
4
5
7
0.50 :±: 0.05*
19+
37*
29*
32*
58
0.45:±:0.15
55
50
33*
35
25*
43
8*
l4t
34
4.1
5.5
5.3
12.1+
8.6 t
12.0t
rate for patients without congestive heart failure in the
MIllS patients (10) was about 7%.
Findings at hospital discharge in all patients discharged
alive from the hospital (Table 2). The two age groups in our
study were similar with regard to findings on the discharge
physical examination. Although both groups had nearly the
same rate of pulmonary congestion on the discharge chest
X-ray study, patients>75 years of age had a slightly higher
cardiothoracic ratio (0.52 ± 0.06 versus 0.50 ± 0.05, respec-
tively, p < 0.001). Patients>75 years of age were taking a
beta-blocker less frequently but other medications more
frequently than were patients in the younger group.
The rates of performance of radionuclide ventriculogra-
phl' and 24 h ambulatory ECG monitoring were similar, but
patients between 65 and 75 years of age more frequently
underwent exercise testing and coronary angiography.
Radionuclide left ventricular ejection fraction was similar
(0.46 ± 0.15 and 0.45 ± 0.15 for the older and younger
groups, respectively). Also, the proportions of patients with
complex ventricular arrhythmias on 24 h ambulatory ECG
monitoring and with a positive exercise test were similar. Of
the patients undergoing coronary angiography, there was a
trend toward a higher incidence of three vessel disease in
patients >75 years of age (\6 [43%] of37) than in those 65 to
75 years of age (74 [32%1 of 230, p = NS).
Outcome after hospital discharge (Table 2). The occur-
rence of angina during the first 6 months of follow-up study
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30 (24'7<)
25 (20%)
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65-75 Years
(n = 125)
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Figure 2. Actuarial survival curves beginning the 10th day after
hospital admission for patients between 65 and 75 years of age
(dashed line) and patients >75 years of age (solid line) stratified
according to the absence (top two curves) or presence (bottom two
curves) of congestive heart failure during hospitalization.
the two age groups do not appear to diverge until about 90
days. The actuarial mortality rate in patients without heart
failure was 3.8% and 3.6% at 90 days and 6.1% and 11.1% at
1 year in the younger and older cohorts. respectively (Fig.
2). In patients with heart failure. it was 14.5% and 16.7% at
90 days in the younger and older group. respectively (Fig. 2).
Cause of death in patients dying after hospital discharge up
to 1 year (Table 3). The percent of patients dying from the
various cardiac causes was not different for patients between
65 and 75 and >75 years of age. Although slightly more
patients died from congestive heart failure in the older
group. about two thirds of deaths in both groups were
sudden or from a new myocardial infarction. Among patients
who had congestive heart failure in the hospital. 55% of
deaths in those between 65 and 75 years old and 58% in those
>75 years old were sudden or due to a new myocardial
infarction. and congestive heart failure was the cause of
death in 21 % and 31 %. respectively. Among patients dying
suddenly or of a new myocardial infarction. 75% of those
between 65 and 75 years of age had congestive heart failure
in the hospital compared with 68% of those>75 years of age;
at hospital discharge. 17% and 7%. respectively. had con-
gestive heart failure. Among patients who died but had at
least one follow-up examination before death. 41 % of those
between 65 and 75 years old and 61% of those >75 years old
experienced angina pectoris. These differences did not reach
Sudden dealh
New myocardial infarction
Congestive heart failure
Other cardiac
Table 3. Cause of Death After Hospital Discharge in 215 Patients
65 to 75 and >75 Years of Age
p (0.001
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Figure 1. Actuarial survival curves beginning the IOlh day after
hospital admission for patients between 65 and 75 years of age
(dashed line) and patients>75 years of age (solid line).
was similar in the two age cohorts. as was the rate of
recurrent nonfatal myocardial infarction. Rates of recurrent
nonfatal infarction were not different for patients with or
without a Q wave index infarction and these rates did not
differ between age groups. Significantly more patients be-
tween 65 and 75 years old had coronary angioplasty or
coronary artery bypass surgery both before 60 days and
during the 1st year than did patients >75 years old. After
hospital discharge. the cardiac mortality rate by I year was
17.6% for patients>75 years old compared with 12.0% for
those 65 to 75 years old (p < 0.01). Although the cardiac
mortality rate was not significantly different for patients with
a Q wave compared with a non-Q wave index infarction in
either age group. the trend was toward a slightly higher
mortality rate in the non-Q wave group in patients>75 years
old and a slightly lower mortality rate in patients 65 to 75
years old. Data in Table 2for total mortality rate also include
patients with indeterminate location of infarction. The car-
diac mortality rate in our younger group was significantly
lower than that in the 65 to 75 year MIllS group (12% versus
19%. p < 0.01) (10).
Figure I shows aell/arial survival curves for hoth aRe
groups ill the Cl/rrellt study after day 10 up to I year.
Because patients>75 years tended to have a longer hospital
stay and a higher in-hospital mortality rate (Table I). in both
subgroups the analysis was commenced at day 10 (the
current average hospital stay for our entire study group)
rather than at hospital discharge. Up to 90 days. the two
curves were remarkably close; thereafter. patients >75
years old experienced a higher mortality rate (p < 0.001)
(Fig. I). By I year. the actuarial mortality rate was 22% for
patients>75 years old compared with 14% for those 65 to 75
years old. When patients were stratified according to the
presence or absence of congestive heart failure (Fig. 2), the
mortality rate was slightly but not significantly higher for
patients >75 years old compared with those 65 to 75 years
old both in patients with (p < 0.08) and in those without (p <
0.07) congestive heart failure; again. the survival curves for
lACC Vol. 16. No.4
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Table 4. Comparison of Factors Related to Mortality for the Two Age Groups in 1,335 Patients
Followed up for I Full Year Versus 215 Dying of Cardiac Cause After Hospital Discharge
Current Study MiLlS
>75 Years 65-75 Years 65-75 Years
Survivors Deaths RR Survivors Deaths RR RR
No. 421 90 914 125
History
Previous MI 3lt 49 1.9 35* 50 1.9 1.9
Cong heart failure 20* 42 2.3 10* 26 2.7 2.1
Angina 46* 7\ 2.4 42"i" 56 1.7 1.4
Diabetes 16::: 25 1.6 16* 29 1.9 1.5
Clinical course
Cong heart failure 56* 73 1.9 45* 75 3.6 1.6
Extension of MI 4 7 1.5 3* 13 3.5
HR >100 beats/min 27 54 2.5 25* 48 2.4
Q wave MI 66 62 0.9 74 65 0.7 0.9
QRS duration 2:0.1 s 44::: 58 1.6 33* 56 2.3
Atrial fib 24 29 1.2 m 26 1.6 1.2
Discharge
S) gallop 5::: II 1.9 3* 19 4.8
Digitalis 42* 59 1.8 26' 52 2.6
Diuretic 45* 73 2.8 30* 46 1.8
Beta-blocker 73 79 1.4 6tH 73 1.7
(nonuse)
Special studies
CTR 2:0.51 61 65 0.8 41 + 54 1.5-7
RN LVEF <0.45 43 55 1.5 41* 78 4.1
Complex VPCs 48::: 64 1.7 46* 70 2.4
*p < 0.00 I. "i"p < 0.01 and :::p < 0.05. means or proportions. survivors versus deaths. CTR = cardiothoracic ratio:
HR = heart rate: RN LVEF = radionuclide left ventricular ejection fraction: RR = risk ratio: other abbreviations as
in Tables I and 2.
statistical significance because of the small number of pa-
tients.
Factors Related to J Year Mortality Rate in
Patients >75 and Between 65 and 75 Years
(Table 4)
Univariate analysis. Table 4 univariately examines prog-
nostic factors in patients discharged from the hospital who
were followed up for the full year compared with those who
had died by 1 year. Many of the variables univariately
important for the 1 year cardiac mortality rate in patients 65
to 75 years of age showed the same trend in the older group.
The magnitude of the differences in prevalence of these factors
between survivors and nonsurvivors tended to be less. and
statistical significance was not always reached with smaller
sample sizes. For some factors. the risk ratios for I year
cardiac mortality appear different for the two groups. but the
respective 95% confidence intervals overlap. When available.
the risk ratios from the MILlS cohort (10) are included in Table
4. Although the MILlS risk ratios are for 4 year total mortality
(without complete follow-up data). they agreed closely with the
ratios in our 65 to 75 year old group. The main exceptions are
congestive heart failure and ejection fraction. but 95% confi-
dence intervals for the risk ratios overlap.
Multivariate analysis. Within each age group. the follow-
ing 13 variables. collected for all patients and found univari-
ately significant for the cardiac mortality at I year after
hospital discharge in one or both age cohorts. were utilized
in a stepwise Cox regression analysis: age. history of previ-
ous myocardial infarction. angina pectoris. congestive heart
failure. diabetes. maximal heart rate. maximal QRS dura-
tion. extension of myocardial infarction. heart failure status
in the hospital. S3 gallop at the discharge physical examina-
tion and use of diuretic drugs. digitalis or beta-blockers at
discharge. Although left ventricular ejection fraction was
highly significant for patients between 65 and 75 years. this
factor was not included in the multivariate analysis because
it is available in only about 60% of the patients. The Cox
regression selected different sets of variables within each age
group. For patients between 65 and 75 years of age. the nine
variables selected in order of importance for 1 year cardiac
mortality were S3 gallop at the discharge physical examina-
tion. infarct extension. heart failure status. age. maximal
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QRS duration, history of diabetes, previous myocardial
infarction, nonuse of a beta-blocker at discharge and use of
digitalis at discharge. For patients>75 years old. the four
variables selected were history of angina pectoris, use of
diuretic drugs at discharge. maximal heart rate and history of
congestive heart failure. Age was an important independent
factor for the younger but not the older group.
Discussion
Previous studies. Our very elderly patients (>75 years
old) resemble somewhat younger patients reported previ-
ously (5-8,10) in that patients were more often women. had
more previous angina pectoris and congestive heart failure
(7,10), were more likely to be nonsmokers and experienced
a higher incidence of congestive heart failure during hospi-
talization than younger groups.
Several previous studies mentioned lack of evidence in
the elderly for an increased incidence of anterior location of
infarction (5,6,8,10) or larger infarction assessed by higher
peak creatine kinase (CK) or MB CK enzyme levels (0),
and our results are consistent with these findings (Table I).
In other reports. it was suggested that myocardial infarction
is less well tolerated in older patients because of preexisting
heart failure (6,7), a decline in myocardial reserve (7), a
higher incidence of multivessel disease (10). age-related
hypertrophy of the left ventricle, reduced ventricular com-
pliance, hypertension and cardiac amyloidosis (10). How-
ever. few data exist relating age to the condition of the
myocardium in humans.
Even patients without congestive heart failure in our very
elderly patients experienced a 14% total mortality rate
(cardiac and noncardiac) by I year. In the general white
population matched for the age and gender distribution with
our patients>75 years of age who survived hospitalization,
an 8% mortality rate at the end of I year would be expected
(30), indicating that in those patients without congestive
heart failure in our study group, other factors were respon-
sible for the increased cardiac and total mortality. Also, in
patients >75 years of age who died. only 55% of those
undergoing radionuclide ventriculography had a depressed
ejection fraction «0.45) compared with 78% among those
who died in the 65 and 75 year age group (Table 4).
We previously investigated (31) the relation of infarct
type (Q or non-Q wave) to in-hospital and postdischarge
mortality. In that analysis (31), patients with Q wave infarc-
tion showed an overall higher in-hospital mortality, but by I
year it was the same for both infarct types. Significantly
increased postdischarge mortality was. however. evident for
patients>70 years of age without prior infarction (31). In the
present analysis, in-hospital mortality was much lower and
postdischarge mortality tended to be slightly higher in the
very elderly patients with a non-Q wave infarction than in
patients with a Q wave infarction, but in patients between 65
and 75 years of age mortality after hospital discharge tended
to be lower in those with non-Q wave infarction.
Comparison with the MILlS study. The younger group of
the present study (n = IJ21) includes the same age range (65
to 75 years) as the older group in MIllS (10) (n = 217), and
these two groups were similar in a number of respects (Table
I). However. the MILlS study found that even though other
risk factors were equally predictive in their patients <65 and
between 65 and 75 years of age. the ejection fraction was not
related to death for patients 65 to 75 years old. In our study
cohort, we previously showed that ejection fraction is not
related to the I year mortality rate in women (32), and in the
present study it was not a significant predictor of death by I
year in patients>75 years old. 44% of whom were women.
The MIllS patients between 65 and 75 years of age also
included a higher proportion of women (37%) than did our
study group (29%). Using 0.40 as a breakpoint for ejection
fraction (as in the MIllS) did not substantially alter our
findings.
Our study in an unselected group of patients indicates
that patients 65 to 75 years of age have a lower I year
mortality rate (12% cardiac, 14% total) than the total mor-
tality rate (19%) in the MIllS study group (10). Although
this subgroup is at increased risk compared with younger
patients, the findings that only about 25% who died in the 1st
year after discharge died from congestive heart failure and
that most died suddenly or from a new infarction suggest that
the same criteria could be used in selecting patients for
coronary angiography (33) and potential revascularization in
this age group as in patients <65 years old.
Age >75 years. In patients>75 years of age, neither the
presence of congestive heart failure during hospitalization
nor increased age was an independent predictor of increased
mortality. A history of angina pectoris was the most impor-
tant factor in the multivariate analysis, and the causes oflate
death resembled those in the younger cohort, with most
patients dying suddenly or from a new infarction. Slightly
fewer patients>75 years of age who died suddenly or of a
new myocardial infarction had congestive heart failure in the
hospital or at discharge compared with the younger group
and more of the very elderly dying of these causes experi-
enced angina pectoris during the early follow-up period.
Thus, selected patients >75 years of age might also be
candidates for coronary angiography according to recently
described criteria (33), provided that their overall health
status does not preclude possible revascularization.
Conservative diagnostic and therapeutic techniques are
traditionally recommended for elderly persons and tended to
be followed in our very elderly patients (Table 2). Treadmill
exercise testing may be safely performed in the elderly
patient and is one method by which the high risk patient
might be identified (34). No deaths or significant complica-
tions were reported by Saunamaki (35) in a series of 62
patients >70 years undergoing treadmill testing soon after
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myocardial infarction. Similarly Deckers et al. (36) per-
formed exercise tests in III patients >64 years old after
myocardial infarction without complications. However, in
these studies (35,36), <50% of the patients were able to
perform an exercise test, emphasizing the need for additional
diagnostic procedures such as dipyridamole thallium perfu-
sion or coronary angiography. Recurrent angina pectoris,
especially while on medical therapy, should also identify the
higher risk patient who should be considered for coronary
angiography (37).
Therapeutic approaches in the elderly. Many trials (16-
24) involving new treatment strategies for acute myocardial
infarction have excluded the elderly. Thus, little information
exists concerning the efficacy of thrombolytic agents, beta-
adrenergic blockers, calcium antagonists or angiotensin-
converting enzyme inhibitors in the elderly. In our study,
fewer patients aged >75 years than younger patients re-
ceived beta-blocker therapy and more received digitalis,
diuretic drugs and antiarrhythmic agents (Table 2). Whether
the evidence for a deleterious effect of digitalis (38) is more
or less pronounced in the elderly has not been investigated.
It has been recommended (39) that intravenous streptoki-
nase therapy not be used in patients ?-75 years of age,
especially in women, because of a higher incidence of major
hemorrhagic complications, and in our very elderly patients.
proportionately more women were encountered. In the
Gruppo Italiano per 10 Studio della Streptochinasi nell'In-
farto Miocardico (GISSI) study (40), no benefit was reported
for streptokinase given to patients >75 years old. However,
in the Second International Study of Infarct Survival
(lSIS-2) (41), patients >70 years old exhibited benefit from
streptokinase alone or in combination with aspirin. Also, the
older patients did not experience an increased rate of com-
plications due to therapy. Thus, the role of thrombolytic
therapy in the elderly remains controversial.
Mechanical reperfusion with coronary anf,?ioplasty (42) or
coronary artery bypass f,?rafting (43-45) can be performed
safely in elderly patients. Dorros et al. (42) reported an 86%
success rate in 242 consecutive patients with chronic coro-
nary heart disease undergoing elective coronary angioplasty
at a mean age of 74.2 years (range 70 to 88). The overall
actuarial survival rate at 72 months was 92% and was not
adversely affected by gender (90% survival for men versus
95% for women). Although definitive long-term follow-up
studies are not yet available for elderly patients undergoing
coronary angioplasty, these results suggest that it might have
a beneficial impact in preventing increased mortality in
selected postinfarction patients.
The findings of Rahimtoola et al. (43) indicate that the
immediate and lonf,?-term results ofselective coronary artery
bypass graft surgery in patients >65 years old are similar to
those in a younger patient group. The operative mortality
rate was 3% for a group 75 to 84 years of age and the 7 year
survival rate in that group was 65%. Recently, Edmunds et
al. (44) published their experience in 100 consecutive pa-
tients ?-80 years of age and reported a 65% survival rate over
a mean follow-up period of 40 months (range 12 to 142) in 41
patients undergoing coronary artery bypass surgery. Loop et
al. (45) noted a higher 8 year survival rate (65%) for their
patients >75 years old who underwent coronary artery
bypass grafting compared with the general population
matched for age and gender; however, female gender and left
ventricular impairment were predictors for a higher opera-
tive mortality rate in this group. Because our elderly patient
group contains a high proportion of women and patients with
congestive heart failure, these findings suggest that coronary
bypass grafting may be appropriate for relatively few very
elderly patients after acute myocardial infarction.
Conclusions, As the population of elderly patients con-
tinues to increase, it is clear that strategies for their manage-
ment after myocardial infarction should be established. The
results of our analyses of patients between 65 and 75 years of
age indicate that this patient group was not at such high risk
(12% I year cardiac mortality rate) and many of these
patients could probably benefit from further diagnostic and
therapeutic approaches. In very elderly patients (>75 years
old), the high proportion of deaths that are sudden or due to
a new myocardial infarction rather than to congestive heart
failure suggests a role for increased use of diagnostic evalu-
ation with procedures such as treadmill exercise testing or
coronary angiography, or both. before 90 days postinfarction
(in those without other severe health problems) in an attempt
to identify patients in this group for potential intervention.
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